Research shows that approximately 24% of women use social media as their primary source of information about perimenopause. The instinct, when encountering this statistic, is often to draw a conclusion about digital literacy, or about the risks of health misinformation online.
A more useful question is what those women are being offered elsewhere.
I ask this not rhetorically. The answer matters for how we understand the social media phenomenon, and for what would actually need to change for women to be better served.
What women consistently report about healthcare
The research on women's experiences of healthcare during the perimenopausal transition is consistent across countries and healthcare systems. Women report feeling dismissed when they raise perimenopausal concerns with their GPs. Symptoms are attributed to normal ageing, stress, anxiety, or depression without the hormonal context being assessed. Recommendations to "wait and see" or "try lifestyle changes" arrive without reference to current clinical guidelines. Wait times for specialist menopause care, where it exists, are measured in months.
Studies show that women wait an average of several years from the onset of perimenopausal symptoms to receiving appropriate diagnosis and support. During that period, they are managing symptoms they cannot name, in a clinical system that often does not recognise what they are describing, with no map for what they are experiencing.
Social media enters this gap. It offers something the clinical encounter often does not: recognition. The first time a woman encounters an account that describes exactly what she has been experiencing - the rage, the sleep disruption, the cognitive fog, the anxiety that arrived from nowhere - and names it as perimenopause, that recognition has real value. Being seen, even by an algorithm-curated feed, when clinical encounters have repeatedly failed to see you, matters.
What social media provides that healthcare doesn't
The value social media provides for perimenopausal women is not primarily informational. It is relational and validating. Community with others experiencing the same thing. Language for experiences that were previously nameless. Permission to take the experience seriously, from people who are taking it seriously, when official channels have consistently minimised it.
There is also genuine information available, some of it accurate and clinically grounded. Clinicians, researchers, and informed advocates use social media platforms to share current evidence. The FIGO 2025 guidelines, the SWAN study findings, the evidence for transdermal estradiol - this information is available online in accessible form in a way it may not be in a ten-minute GP appointment.
The value social media provides is not primarily informational. It is relational and validating. Permission to take the experience seriously, when official channels have not.
The limitation of social media
The limitation of social media as a primary source of perimenopause information is not that it contains inaccurate content - though it does. It is structural. Social media cannot assess individual circumstances, medical history, risk factors, or contraindications. It cannot replace the clinical judgement that determines whether hormonal therapy is appropriate for a specific woman, at what dose, and in what formulation. It amplifies what is engaging over what is accurate. And the confidence with which information is presented online bears no reliable relationship to the quality of the evidence behind it.
Women who have been managing perimenopausal symptoms for years through information gathered from social media often arrive in clinical settings with a sophisticated but uneven understanding - knowing certain things very well, having significant gaps in others, and sometimes holding convictions about treatments that are not supported by the evidence they believe they are grounded in.
This is not a criticism of those women. It is a predictable consequence of a system that left them to navigate a complex medical transition without adequate support, and they found what they could.
The right clinical question
The clinical and systemic response to 24% of women using social media as primary perimenopause information is not to address social media literacy. It is to ask what would need to change in healthcare for women not to need it as a primary source.
That includes training more clinicians in perimenopausal care. Ensuring that current guidelines - including the 2025 FIGO recommendations on mental health screening and treatment - are integrated into primary care practice. Reducing wait times for specialist care. Creating clinical environments where women feel heard rather than managed or minimised.
It also includes honest engagement from clinicians who use social media themselves. Those of us who write and post about perimenopause in public spaces have a responsibility to accuracy - to citing actual research, to naming the limits of our evidence, to flagging where the field is uncertain. The reach of social media in this space is real. The responsibility that comes with it is real.
What informed information-seeking looks like
For women navigating this landscape, a few principles are practically useful. Look for sources that name specific research and allow you to check it, rather than citing "studies show" without reference. Be cautious with accounts whose primary output is product promotion - the incentive structure matters. Bring what you find online to clinical appointments as questions rather than conclusions. Ask your clinician whether they are current with the FIGO 2025 guidelines on menopausal mental health. If not, that is useful information.
And recognise that finding a community online that sees your experience clearly is not the same as finding clinical guidance. The community value is real. The clinical gap it is filling is the problem to address.